Rezolute, Inc. (RZLT) vs Strata Critical Medical, Inc. (SRTA)
A side-by-side comparison of Rezolute, Inc. and Strata Critical Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RZLT
Rezolute, Inc.
$4.32HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SRTA
Strata Critical Medical, Inc.
$4.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — RZLT vs SRTA
growth of $100 · dividends reinvested · last 7yRZLT -32.9% (-5.5%/yr)SRTA -50.7% (-9.6%/yr)RZLT compounded faster over this window
RZLT SRTA
RZLT vs SRTA: by the numbers
- •RZLT is the larger company ($416M vs $411M market cap).
- •SRTA is profitable (15.71% net margin) while RZLT runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | RZLT | SRTA |
|---|---|---|
| P/E ratio | N/A | 9.54 |
| P/S ratio | N/A | 1.61 |
| P/B ratio | 4.13 | 1.47 |
Profitability
| Metric | RZLT | SRTA |
|---|---|---|
| Gross margin | 0.00% | 20.56% |
| Operating margin | 0.00% | -7.97% |
| Net margin | 0.00% | 15.71% |
| ROE | -77.06% | 14.40% |
| ROIC | -81.80% | -7.11% |
Growth (annualized)
| Metric | RZLT | SRTA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 46.05% |
| Total return CAGR (5Y) | -9.57% | -13.77% |
Frequently asked
- Is RZLT or SRTA more profitable?
- SRTA runs the higher net margin — RZLT at 0.00% versus SRTA at 15.71%.
- How have RZLT and SRTA total returns compared?
- Over the past 5 years, RZLT delivered -9.57% and SRTA delivered -13.77% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Strata Critical Medical P/E ratioRezolute ROEStrata Critical Medical ROERezolute operating marginStrata Critical Medical operating marginRezolute revenue growthStrata Critical Medical revenue growthRezolute free cash flowStrata Critical Medical free cash flow
Rezolute & Strata Critical Medical appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.